Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic human disease. About 85% of ADPKD cases are caused by mutations in the PKD1 gene, whereas the remaining cases are caused by defects in the PKD2 gene. The PKD1 protein, polycystin-1 (PC1), is a large integral protein whose function is not clear. PC2, the PKD2 protein, is a membrane protein believed to function as a Ca2+ permeable cation channel in the endoplasmic reticulum and plasma membrane. Recent findings suggest that the PC1/PC2 complex may function as a mechanoreceptor in primary cilia of mouse embryonic renal epithelia and, more speculatively may contribute to flow-regulated epithelial morphogenesis. We will study the function of PC1/PC2 in primary cultures of normal human proximal renal epithelial cells, and of ADPKD cyst cells with the following Specific Aims: 1. Complete the characterization of flow-induced Ca 2+ signaling and 28 pS cation channel activity in normal human renal epithelial cells and ADPKD cells, and test the hypothesis that they are related. 2.Test effect of modulation of PC2 expression in human kidney cells on flow-induced Ca2+ signaling and on 28 pS cation channel activity. 3:Compare effects of expression of CD16.7-PKD1 (115-226) and full-length polycystin 1 on flow-induced Ca2+ signaling and 28 pS cation channel activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK069049-01
Application #
6837991
Study Section
Special Emphasis Panel (ZRG1-F10 (21))
Program Officer
Rankin, Tracy L
Project Start
2004-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$42,976
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215